Pennsylvania Implements Sales Ban on Most Vaping Devices
Pennsylvania now restricts legal sales to products from only six vaping device manufacturers evaluated by federal regulators.
Tag: US healthcare policy
All
Latest
Pennsylvania Implements Sales Ban on Most Vaping Devices
Pennsylvania now restricts legal sales to products from only six vaping device manufacturers evaluated by federal regulators.
Read More
ATS, CHEST Join Legal Challenge Against FDA E-cigarette Policy
The ATS and CHEST filed a joint amicus brief supporting a lawsuit against FDA guidance that permits unauthorized e-cigarettes and nicotine pouches to remain on the US market.
Read More
Prescription Drug Prices Continue to Surge
Initial prices for brand-name medications climbed steadily over two decades, with no immediate slowdown following the Inflation Reduction Act.1
Read More
US Facing Shortage of Thoracic Surgeons
A national analysis warns that surgeon supply will fall short of patient demand, with thoracic surgery and rural healthcare delivery facing steep deficits.
Read More
California Moves to Ban High-Silica Engineered Stone Countertops to Protect Workers
Cal/OSHA issued draft rules to prohibit the fabrication of artificial stone products containing more than 1% crystalline silica, citing lung risks to workers.
Read More
FDA Launches Pilot Program to Speed Early Clinical Trials
The FDA’s Expedited Investigational New Drug (IND) Pilot pairs drug sponsors with research institutions to reduce startup delays for early human studies.
Read More
CDC Merges Influenza, Coronavirus Divisions Into Unified Respiratory Unit
The federal agency restructured its flu and COVID-19 units into a unified Influenza and Respiratory Viruses Division (IRVD).
Read More
Garnering Public Support for Bans on Menthols, Flavored Cigars
Correcting misconceptions about tobacco sales restrictions could build community support and advance respiratory health initiatives.
Read More
IDSA Concerned Over Federal Plan to Overhaul Infectious Disease Research
Leading medical societies warn that proposed changes and funding delays at the National Institutes of Health could disrupt active studies and patient care.
Read More
How Big Tobacco Helped Derail a Menthol Cigarette Ban
Ninety-seven percent of the 246,000+ public comments sent to the FDA before it withdrew a proposed menthol cigarette ban were non-unique form letters, and half traced back to Big Tobacco.
Read More
Trump Administration Orders Separate MMR Vaccinations
President Donald Trump signed an executive order on Monday that revises federal recommendations for the childhood vaccination schedule, according to multiple media reports including the AP.
Read More
Worse COPD, Pneumonia Outcomes at Private Equity Hospitals
Patients with pneumonia or COPD faced higher mortality risks and readmission at facilities owned by private equity firms, according to new research.
Read More
SOAR Act Reaches 50 Bipartisan Cosponsors
The Supplemental Oxygen Access Reform (SOAR) Act aims to modernize Medicare benefits, restore access to liquid oxygen, and increase the availability of respiratory therapists for patients.
Read More
FDA Outlines Enforcement Priorities for E-cigarettes and Nicotine Pouches
New FDA will not prioritize enforcement against unauthorized vaping and nicotine pouch products that have filed premarket applications.
Read More
Telemedicine Expansion Did Not Increase Healthcare Spending, Patient Visits
Expansion of telemedicine during and after the COVID-19 pandemic did not result in a statistically significant increase in healthcare spending or the total number of medical visits.
Read More
CMS/FDA Launch New Pathway to Fast-Track Medicare Access for Medical Devices
The RAPID coverage pathway aims to reduce delays between FDA authorization and Medicare coverage for breakthrough technologies.
Read More
Senate Investigation: Flovent Discontinuation Profited GSK, Harmed Kids
Pulling Flovent from the market in 2024 resulted in GSK profits and harm to pediatric asthma patients, according to a US Senate investigation reported by CNN.
Read More
Court Blocks HHS Revisions to Child Vaccine Schedule
A US district court blocked HHS Secretary Robert Kennedy Jr’s recent moves to revise the federal childhood vaccine schedule and overhaul of the CDC’s vaccine advisory board, according to multiple media reports including Reuters.
Read More
Link Between COVID Response, State Tax Policies
US states more dependent on sales tax revenue tended to implement shorter stay-at-home orders during the early stages of the COVID-19 pandemic.
Read More
FDA Launches PreCheck Pilot Program for Pharmaceuticals
The US FDA is accepting requests to participate in the FDA PreCheck pilot program, designed to streamline US-based manufacturing of pharmaceuticals.
Read More
CDC Surveillance Databases Inexplicably Halt Updates
Forty-six percent of frequently updated CDC public health databases have halted updates, including those that track vaccination-related information, respiratory diseases, and drug overdose deaths.
Read More
US Withdraws from World Health Organization
The Trump administration has terminated the United States’ membership in the World Health Organization, claiming WHO mishandled the COVID-19 pandemic and failed to adopt needed reforms.
Read More
AAP Opposes HHS Changes to Childhood Immunization Schedule
AAP president Andrew D. Racine is raising alarms over the federal government’s removal of several vaccinations from its Childhood Immunization Schedule.
Read More
CDC/HHS Remove Vaccines from Childhood Immunization Schedule
The CDC and HHS reduced the federally recommended childhood immunization schedule from 17 to 11 vaccinations, removing shots for seasonal flu and other infectious diseases.
Read More